EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study

Hayahide Ooi, Yuki Asai iD, Yoshiki Koriyama, Masaaki Takahashi

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280241255837 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Hayahide Ooi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Hospital Organization Mie Chuo Medical Center, Tsu, Japan. Hauptthemen laut MEDLINE: Piperacillin, Tazobactam Drug Combination, Anti-Bacterial Agents, Liver, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: japan society for the promotion of science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Piperacillin/tazobactam (PIPC/TAZ), which is a combination of a beta-lactam/beta-lactamase inhibitor, often causes liver enzyme abnormalities. The albumin-bilirubin (ALBI) score is a simple index that uses the serum albumin and total bilirubin levels for estimating hepatic functional reserve. Although patients with low hepatic reserve may be at high risk for drug-induced liver enzyme abnormalities, the relationship between PIPC/TAZ-induced abnormal liver enzymes levels and the ALBI score remains unknown.

Objective

This study aimed to elucidate the relationship between PIPC/TAZ-induced abnormal liver enzyme levels and the ALBI score.

Methods

This single-center retrospective case-control study included 335 patients. The primary outcome was PIPC/TAZ-induced abnormal liver enzyme levels. We performed COX regression analysis with male gender, age (≥75 years), alanine aminotransferase level (≥20 IU/L), and ALBI score (≥−2.00) as explanatory factors. To investigate the influence of the ALBI score on the development of abnormal liver enzyme levels, 1:1 propensity score matching between the ≤−2.00 and ≥−2.00 ALBI score groups was performed using the risk factors for drug-induced abnormal liver enzyme levels.

Results

The incidence of abnormal liver enzyme levels was 14.0% (47/335). COX regression analysis revealed that an ALBI score ≥−2.00 was an independent risk factor for PIPC/TAZ-induced abnormal liver enzyme levels (adjusted hazard ratio: 3.08, 95% coefficient interval: 1.207-7.835, P = 0.019). After 1:1 propensity score matching, the Kaplan-Meier curve revealed that the cumulative risk for PIPC/TAZ-induced abnormal liver enzyme levels was significantly higher in the ALBI score ≥−2.00 group (n = 76) than in the

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Piperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsLiverChemical and Drug Induced Liver InjuryHumansMaleRetrospective StudiesFemaleCase-Control StudiesAgedMiddle AgedBilirubinRisk FactorsAlanine TransaminaseAged, 80 and overLiver Function TestsSerum Albumin

Stichwörter der Autor:innen

albumin-bilirubin scoredrug-induced liver injuryhepatic functional reserveliver enzymepiperacillin/tazobactam

Substanzen

Piperacillin, Tazobactam Drug CombinationBilirubinAnti-Bacterial AgentsAlanine TransaminaseSerum Albumin

Autor:innen und Institutionen

  • Department of Pharmacy, National Hospital Organization Mie Chuo Medical Center, Tsu, Japan.
  • Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University, Tsu, Japan.
  • Graduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan.

ORCID-Profile: Yuki Asai

Förderung

  • japan society for the promotion of science

Zitieren

APA

Ooi, H., Asai, Y., Koriyama, Y., & Takahashi, M. (2025). Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241255837

Vancouver

Ooi H, Asai Y, Koriyama Y, Takahashi M. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241255837

BibTeX
@article{Ooi2025,
  author = {Ooi, Hayahide and Asai, Yuki and Koriyama, Yoshiki and Takahashi, Masaaki},
  title = {Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280241255837}
}
Kostenlos starten →